An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

NCT00092170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections
Pelvic Infections

Interventions

DRUG: MK0826, ertapenem sodium
DRUG: Comparator: Ticarcillin/Clavulanate

Sponsor

Merck Sharp & Dohme LLC